Aug 07, 2019 / 03:00PM GMT
Jason Richard Mills - Canaccord Genuity Corp., Research Division - MD of Research & Analyst
Hi, there, everybody. My name is Jason Mills. I'm the senior medical devices analyst at Canaccord Genuity. Four rooms, not surprising for one of the more dynamic companies in medical devices, in my opinion, Penumbra.
We have both the CEO, Adam Elsesser; and CFO, Sri Kosaraju, with us today. And really appreciate you coming again. Just having reported your second quarter results, and hopefully, our conference didn't make you report soon than you were. But it certainly comes during raining season, which is an opportune timing in some respect.
But let's start, Adam. You had a chance to go through your business last night. I don't know that everyone, given there's a lot going on, had a chance to see your results. Maybe you and Sri can spend a minute talking about the highlights from your second quarter results and sort of -- we can get into sort of what that implies for your business overall.
Adam Elsesser - Penumbra, Inc. - Co-Founder, Chairman & CEO
Penumbra Inc at Canaccord Genuity Growth Conference Transcript
Aug 07, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers